These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 34058986)

  • 1. Heterologous vaccine interventions: boosting immunity against future pandemics.
    Marín-Hernández D; Nixon DF; Hupert N
    Mol Med; 2021 May; 27(1):54. PubMed ID: 34058986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
    Vashishtha VM
    Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
    Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
    Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
    Fritschi N; Curtis N; Ritz N
    Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
    Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
    Front Immunol; 2021; 12():812176. PubMed ID: 35095907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
    Pasco ST; Anguita J
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence between global BCG vaccination and COVID-19 pandemic.
    Islam MZ; Zahan MK; Al-Bari MAA
    J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
    Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
    Front Immunol; 2021; 12():632478. PubMed ID: 33763077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous effects of vaccination and trained immunity.
    Gyssens IC; Netea MG
    Clin Microbiol Infect; 2019 Dec; 25(12):1457-1458. PubMed ID: 31158520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of vaccines on heterologous adaptive immunity.
    Messina NL; Zimmermann P; Curtis N
    Clin Microbiol Infect; 2019 Dec; 25(12):1484-1493. PubMed ID: 30797062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
    Parmar K; Siddiqui A; Nugent K
    Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific effects of BCG vaccine on viral infections.
    Moorlag SJCFM; Arts RJW; van Crevel R; Netea MG
    Clin Microbiol Infect; 2019 Dec; 25(12):1473-1478. PubMed ID: 31055165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG vaccination in health care providers and the protection against COVID-19.
    Netea MG; van der Meer JW; van Crevel R
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33306484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
    Gong W; Mao Y; Li Y; Qi Y
    Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.